Study of Biomarkers in Hemophilic Arthropathy

Clinical Trial Title

Expression of biomarkers in hemophilic arthropathy: Repository of surgical tissue samples and biomarkers in patients with hemophilia.

Contact Information

Narine Hakobyan, PhD

Clinical Trial Protocol Description:

Evaluating long term changes in molecules in hemophilia joints.

  1. Approximately two teaspoons (10 ml) of blood drawn from the arm.
  2. One to two teaspoons (5-10 ml) of synovial fluid drawn from the joint right before starting your regular surgical procedure. Synovial fluid is a thick, sticky lubricant present in the joint space between bones.
  3. Three to four small (2-3 mm / 0.08-0.12 inches) synovial tissue samples taken before the removal of scar tissue in the joint as part of the management in the case of a hemophilic joint or fixing the tear in subjects with joint trauma.

Clinical Trial Eligibility Criteria:

To inquire about your eligibility, please call the contact number provided.

Study Details

Clinical Trial Investigator

Narine Hakobyan, PhD

Contact Information

Narine Hakobyan, PhD

(312) 942-3034


RUSH University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more